The new crown Covid-19 epidemic will never see again before the end of this year
The United States will soon have an "oral solution for the treatment of the new coronavirus." Patients who take the drug at home for 5 days can completely eliminate the new coronavirus and recover completely.
The drug is translated as "Monapinavir" (Monapinavir), which was jointly developed by two major pharmaceutical companies, "Rigibel" (Rigibel) in Germany and "Merck" (Merck) in the United States, and has successfully completed the first phase and The second phase clinical trial, the effect is 100%.
Forbes report: "Molnupiravir: New Hope for Prevention and Treatment of Covid-19 and Other Dangerous Viruses"
A new Covid-19 treatment has completed the second phase of human trials, and the results are promising. According to a Merck press release, Molnupiravir, developed by Ridgeback Biotherapeutics LP and Merck, has reached the end point of shortening the duration of Covid-19 infection. This endpoint will be further studied after the complete data of the trial is released.
Once symptoms appear, respiratory viruses such as influenza virus, respiratory syncytial virus and now Covid-19 have unique treatment challenges. Because respiratory virus infections and symptoms are usually short-lived, the immune system quickly suppresses virus replication. Common forms of antiviral drugs, such as Tamiflu and Xofluza for influenza, must now be used with monoclonal antibodies against Remdesivir and Covid-19 within a few days of infection to reduce the severity of symptoms and the duration of infection.
For respiratory antiviral drugs, their ideal use is for those who have recently been exposed to viruses from family members or workplaces. After known exposure, the influenza A antiviral drug Xofluza reduced the spread by 80% in a close home environment. For Covid-19, monoclonal antibodies have been shown to achieve similar close-range transmission effects, but they have a problem. Unlike Xofluza, monoclonal antibodies need to be infused at home. Xofluza and similar antiviral drugs are pill-based, can be used at home, and can be taken quickly after exposure. This new drug, Molnupiravir, may be a substitute for Covid-19 similar to Xofluza. In addition to the vaccine, it may be a powerful supplement to our reserve, especially for variants that seem to evade the vaccine.
